Laparoscopic Power Morecellators Market to be USD 245.2 Mn by 2032

The global laparoscopic power morcellators market is set to reach USD 147.7 million valuation in 2025. It is forecasted to have a USD 245.2 million valuation by 2032, displaying a CAGR of 7.5% during the forecast period (2025-2032).  

Increasing gynecological procedures and alarming levels of obesity among the masses will drive the laparoscopic power morcellators market growth. Procedures such as hysterectomy, endometriosis, and ovarian cystectomy require the use of devices like the laparoscopic power morcellator (LPM) to cut tissues into smaller divisions. Rising occurrences of benign tumors in women and product approvals by regulatory authorities are likely to fuel the market growth over the forecast period.

Key Market Insights

The laparoscopic power morcellators market growth is driven by the rising numbers of gynecological procedures, adoption of containment morcellation techniques, and supportive regulatory norms supporting safe surgeries and patient care.

• By application, the myomectomy segment is anticipated to capture a significant market share during the forecast period. Increasing preference for this procedure, as it allows women to remove uterine fibroids and remain fertile, is likely to drive the segment growth in the laparoscopic power morcellators market. The inclination towards robotic surgeries and minimally invasive surgeries can usher in continuous demand.
• By end user, the surgical centers segment is expected to capture a 42.1% share of the laparoscopic power morcellators market in 2025. The demand for minimally invasive surgeries and cost-effective surgery costs in surgical centers are factors expected to drive the market growth over the forecast period. Low post-surgical complications in laparoscopy as well as benefits of faster procedure time and same-day patient release in comparison to hospitals can bode well for the segment.
• Region-wise, Asia Pacific is expected to exhibit a robust growth rate over the forecast period owing to the awareness of uterine health among women and increased spending on health. The rising preference for minimally invasive procedures by patients and doctors is expected to drive the regional laparoscopic power morcellators market growth. The rise in medical tourism and interest in preventive care are factors likely to fuel the regional market growth.

The full report is now available for purchase: https://www.coherentmarketinsights.com/market-insight/laparoscopic-power-morcellators-market-4905

Laparoscopic Power Morcellators Market Report Coverage

Report Coverage	Details
Market Revenue in 2025	USD 147.7 million
Estimated Value by 2032	USD 245.2 million
Growth Rate	7.5%
Historical Data	2020–2024
Forecast Period	2025–2032
Forecast Units	Value (USD billion)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	By Application and End User
Geographies Covered	North America (U.S. and Canada), Latin America (Brazil, Mexico, Argentina, and Rest of Latin America), Europe (Italy, France, Germany, Russia, U.K., Spain, and Rest of Europe), Asia Pacific (India, China, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific), the Middle East (GCC Countries, Israel, and Rest of Middle East), and Africa (North Africa, South Africa, and Central Africa)
Growth Drivers	Increasing Prevalence of Uterine Leiomyomata (UL) in Women Increasing Product Approvals by Regulatory Authorities
Opportunities	Laparoscopy with Tissue Containment Systems Regulatory Norms Supporting Safe Surgeries
Trends	Ease in Restrictions of Elective Procedures Minimally Invasive Surgeries
Restraints & Challenges	Stringent Regulatory Prices Increasing Product Recalls by Regulatory Authorities

Market Dynamics

The laparoscopic power morcellators market is forecasted to showcase steady growth due to advancements in robotic surgical assistants and strides in the design and function of LPMs. For instance, Momentis Surgical received FDA 501(k) clearance for its Anovo robotic surgical platform in October 2024. The platform can be used by surgeons for performing laparoscopic-assisted gynecological procedures with higher precision.

Government initiatives for improving the healthcare infrastructure and making surgeries safe for women are anticipated to drive the laparoscopic power morcellators market growth over the forecast period. Healthcare federal agencies are advocating for the use of LPMs for improving patient care and reducing healthcare costs of gynecological procedures. Investments in modernizing healthcare infrastructure in developing regions and favorable regulatory frameworks can induce significant market growth.

Market Opportunities

Laparoscopy with Tissue Containment Systems

The adoption of containment morcellation techniques or laparoscopy with tissue containment systems are seeing increased adoption owing to regulatory approval by federal medical safety device agencies worldwide. For instance, the U.S. Food and Drug Administration’s (FDA) Center for Devices and Radiological Health outlined the approval of containment systems in laparoscopic surgeries and the use of LPMs in February 2020. The laparoscopic power morcellators market is expected to gain from this shift in the attitudes of federal regulatory agencies and enjoy a surge in market demand over the forecast period.

Market Challenges

High Costs of Advanced Morcellation Devices

The high costs of advanced morcellation devices can hamper the laparoscopic power morcellators market growth. New features integrated in the latest LPMs such as containment systems and new cutting mechanisms come at a premium cost. This can create a barrier for small healthcare facilities and hospitals in developing regions.

Analyst’s View

“The laparoscopic power morcellators market is set for massive growth over the forecast period owing to a huge preference for minimally invasive surgeries by patients and doctors,” quips Ms. Manisha Vibhute, a management consultant working in Coherent Market Insights.

“The rising cases of uterine fibroids among women and the availability of morcellation procedures for hysterectomies can drive market demand significantly. The Asia Pacific region is expected to showcase a strong growth rate during the forecast period owing to the establishment of state-of-the-art medical infrastructure and rise in medical tourism among nations.”

“However, stringent regulations imposed on the use of power morcellators and safety concerns regarding the spread of uterine cancer during morcellation procedures can limit market growth.”

Competitor Insights

• Richard Wolf GmbH
• Advin Healthcare
• Medtronic
• LiNA Medical
• Endomedium
• Nouvag AG
• Blue Endo
• Lumenis (Boston Scientific Corporation)
• Olympus Corporation
• Karl Storz GmbH
• RUDOLF Medical GmbH
• Hangzhou Kangji Medical Instruments

Market Segmentation

• Application
• Hysterectomy
• Myomectomy
• Others
• End User
• Hospitals and Clinics
• Surgical Centers

Regional Insights

• North America
  • U.S.
  • Canada
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America
• Europe
  • Italy
  • Germany
  • U.K.
  • Spain
  • France
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • South Korea
  • India
  • Japan
  • Australia
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • North Africa
  • Central Africa
  • South Africa